Navigation Links
CenterWatch to Introduce Key Findings from Surveys on Physician Referrals to Clinical Trials and Clinical Trial Volunteer Experiences at DIA Meeting
Date:6/18/2009

CenterWatch will present never-before released results from two annual surveys at the upcoming DIA Meeting in San Diego, Calif.

Boston, Mass. (PRWEB) June 18, 2009 -- CenterWatch, a global source for clinical trials information, will present never-before released results from two annual surveys aimed at better understanding physician referrals to clinical trials and study volunteer experiences at DIA's 45th Annual Meeting, June 22-24, 2009, in San Diego, Calif.

CenterWatch's Director of Market Research, Mary Jo Lamberti, Ph.D., will present analysis of 250 physician responses worldwide focusing on factors surrounding physicians' comfort level with referring patients into trials. Her findings will include concerns about trial location, accessibility of a trial for a patient, and general knowledge about a patient's particular disease.

From the volunteer viewpoint, Paul Dewberry, Senior Research Analyst at CenterWatch, will discuss patient experiences in trials across all disease states and will disclose new data on trial participation compensation for study volunteers, which was not previously captured on prior years' surveys. Responses were gathered from approximately 670 volunteers who participated in phase I-IIIb studies, the largest response since the benchmark survey was first released in 2004.

"This year we received more volunteer responses than any other. Additionally, the responses to open-ended questions were superior in quality," Lamberti said. "Patients were more willing to give detailed information which has resulted in much better data and subsequent analysis."

For more information on this presentation and other CenterWatch speaking engagements, visit http://www.centerwatch.com/about-centerwatch/events/index.htm.

About Mary Jo Lamberti, Ph.D.
Mary Jo Lamberti, Ph.D. is the editor of the CenterWatch sourcebook, State of the Clinical Trials Industry and has extensive experience conducting research and evaluation in both academia and in the clinical trials industry. She is a frequent speaker at industry conferences and has published articles in several trade magazines. Dr. Lamberti holds a B.A. from Wellesley College and a Ph.D. from Boston University.

About CenterWatch
Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. We provide proprietary data and information about clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. CenterWatch was also the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates. Today, we have one of the largest databases of clinical trials actively seeking patients on the Internet.

###

Read the full story at http://www.prweb.com/releases/2009/06/prweb2541524.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Jobson Medical Information LLC Acquires CenterWatch and New England IRB From Thomson Healthcare
2. HealthFrontier Introduces New Innovation in Web-Based Remote Health Monitoring Technology
3. Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW
4. Noteworthy Medical Systems Introduces NetPay(TM)
5. Language Technologies Introduces ReadSmart Edition Apps(TM) for the iPhone(TM) and iPod(R) Touch; Unique Apps Improve Ergonomics of Reading while Retaining Look and Design of Print Books
6. CEP America Introduces ER Forum Blog
7. High Activity, Plant Based Diamine Oxidase Enzyme Introduced by Bio-Research Products
8. Autism Family Foundation Introduces The Robert J. Keegan Family Center for Autism
9. Clinical Innovations Introduces New Circumcision Device
10. TOPAZ Technologies Introduces Biosafety Software Solution
11. BellaDerm(TM), a Unique Human Skin Tissue Implant for Facial and Body Contouring, is Introduced by MTF
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... Foundation, the national charitable foundation serving the footwear industry, has broken all previous ... more than 130 companies across 23 states during the months of April and ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Awakening , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress ... Onnit brain and mood optimization products to the store is just one more ...
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... and author of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related ... 2016 and podcasted thereafter . Dr. Bernie Siegel, author of a plethora ...
(Date:4/29/2016)... STAMFORD, CONNECTICUT (PRWEB) , ... April 29, 2016 , ... ... 5K Run/Walk” at Cove Island Park on Sunday, with sunny skies, a light breeze ... event, raising nearly $33,000. , The 5k Run and Walk and 1-mile ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ... on the development of oral drug delivery systems, announced today ... conference, presented by Joseph Gunnar & Co. LLC, ... York . Nadav Kidron , CEO of Oramed, ... Presentation Details:   PIONEERS 2016, presented by ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... April 27, 2016   ... Growth in Recurring Consumable Sales  Clinical sales ... Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, ... sales for the first quarter ended March 31, 2016 ... execution of its commercial strategy. First Quarter ...
Breaking Medicine Technology: